ATLANTA, GA, USA, April 23, 2024 /EINPresswire.com/ -- The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie ...
Applied Therapeutics, Inc. announced promising 18 and 24-month results from the INSPIRE Phase 2/3 trial of govorestat, a treatment for Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD).
This day emphasizes patient empowerment through health and wellness workshops designed to improve the quality of life. Attendees will enjoy interactive sessions, community-building opportunities, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results